Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Dtlelectrode Attached Without Energy

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Dtlelectrode Attached Without Energy1
  • Transcorneal Electrical Stimulation1

Active Sponsors

  • Okuvision GmbH1

Top Investigators

Related Conditions

  • Hereditary Autosomal Dominant Optic Atrophy1
  • Primary Open Angle Glaucoma1
  • Nonarthriticanteriorischemic Opticneuropathy1
  • Dry Age Related Macular Degeneration1
  • Retinal Vein Occlusion1

Activity Timeline